参考文献/References:
[1] 赵 宁,于洪丹,冯 珍,等.红景天苷抑制高糖诱导大鼠视网膜Müller细胞的凋亡[J].中国组织工程研究,2021,25(11):1664-1669.
[2] 蒋 现,颜繁诚,李树宁,等. Müller细胞在视网膜损伤中对视神经节细胞影响的研究进展[J].眼科新进展,2020,40(7):691-695,700.
[3] 赵珍珍. Müller细胞重编程参与视网膜再生研究进展[J].中华实验眼科杂志,2020,38(10):885-889.
[4] 郭建强,赵俊宏,张分队,等.2型糖尿病视网膜病变患者血清HbA1c、CysC检测及临床意义[J].陕西医学杂志,2020,49(5):619-622.
[5] 周鹏翔,信 波,宋晓鹏,等.CircAKT3对视网膜母细胞瘤细胞SO-Rb50增殖和凋亡的影响[J].陕西医学杂志,2020,49(8):932-935.
[6] 刘 培,彭 俊,李书楠,等.益气养阴活血利水法联合康柏西普对非增殖期糖尿病视网膜病变患者视网膜电图的影响[J].陕西中医,2020,41(6):728-732.
[7] Franciosi AN,Carroll TP,Mcelvaney NG.Pitfalls and caveats in α1-antitrypsin deficiency testing:A guide for clinicians[J].Lancet Respir Med,2019,7(12):1059-1067.
[8] Janciauskiene S,Wrenger S,Immenschuh S,et al.The multifaceted effects of alpha1-antitrypsin on neutrophil functions[J].Front Pharmacol,2018,9(11):341.
[9] Janssen R,Piscaer I,Franssen FME,et al.Emphysema:Looking beyond alpha-1 antitrypsin deficiency[J].Expert Rev Respir Med,2019,13(4):381-397.
[10] Lubrano V,Balzan S.Role of oxidative stress-related biomarkers in heart failure:Galectin 3,α1-antitrypsin and LOX-1:New therapeutic perspective[J].Mol Cell Biochem,2020,464(1-2):143-152.
[11] 刘思妍,王 芯,潘奕璇,等.基于视网膜Müller细胞的地黄调节AGEs干预下HIF-1α表达的谱效关系研究[J].中成药,2020,42(1):217-221.
[12] 步绍翀,张 哲,王 琼,等.结缔组织生长因子刺激后视网膜Müller细胞基因表达谱的转录组学分析及验证[J].中华眼底病杂志,2020,36(12):964-970.
[13] 刘文强,冯 闯,左中夫,等.PI3K/Akt信号通路对高糖状态下视网膜Müller细胞的影响[J].眼科新进展,2020,40(11):1024-1028.
[14] Manne V,Kowdley KV.Alpha1-antitrypsin deficiency:A cause of chronic liver disease[J].Clin Liver Dis,2020,24(3):483-492.
[15] Bari E,Ferrarotti I,Torre ML,et al.Mesenchymal stem/stromal cell secretome for lung regeneration:The long way through “pharmaceuticalization” for the best formulation[J].J Control Release,2019,309(5):11-24.
[16] Blanco I,Lipsker D,Lara B,et al.Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency:An update[J].Eur Respir Rev,2016,174(4):753-62.
[17] 高 爽,沈 玺.小胶质细胞与Müller细胞间的交互作用机制在缺血性视网膜病变中的研究进展[J].中华眼底病杂志,2020,36(1):74-78.
[18] 杨 梅,胡秋梅,黄艳明.视网膜Müller细胞中谷氨酸受体2的表达分析[J].局解手术学杂志,2020,29(12):941-944.
[19] Ruscio M,Vernia F,Ciccone A,et al.Surrogate fecal biomarkers in inflammatory bowel disease:Rivals or complementary tools of fecal calprotectin[J].Inflamm Bowel Dis,2017,24(1):78-92.
[20] Ferrarotti I,Ottaviani S,Silvestri A,et al.Update on α(1)-antitrypsin deficiency[J].Breathe(Sheff),2018,14(2):17-24.
[21] Patrucco F,Venezia L,Gavelli F,et al.Alpha1-antitrypsin deficiency:What's new after european respiratory society statement[J].Panminerva Med,2018,60(3):101-108.
[22] Schipper HM,Song W,Tavitian A,et al.The sinister face of heme oxygenase-1 in brain aging and disease[J].Prog Neurobiol,2019,172(8):40-70.
[23] Stolk J,Carreto L,Morrison M,et al.Utility of routine screening for alpha-1 antitrypsin deficiency in patients with bronchiectasis[J].Molecules,2020,75(7):592-593.
[24] Vignes S,Bellanger J.Primary intestinal lymphangiectasia(Waldmann's disease)[J].Rev Med Interne,2018,39(7):580-585.